Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant

Retina

Volumn 34, Issue 4, 2014, Pages 719-724

  Lazic, Ratimir ^a   Lukic, Marko ^a   Boras, Ivan ^a   Draca, Natasa ^a   Vlasic, Marko ^a   Gabric, Nikica ^a   Tomic, Zoran ^a  

^a University Eye Hospital Svjetlost   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; DEXAMETHASONE; VASCULOTROPIN INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; DIABETIC MACULAR EDEMA; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; INTRAVITREAL IMPLANT; LOW LEVEL LASER THERAPY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTICAL COHERENCE TOMOGRAPHY; PROSPECTIVE STUDY; RETINAL THICKNESS; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHRONIC DISEASE; DEXAMETHASONE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DRUG IMPLANTS; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 84897576584     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182a48958     Document Type: Article

References (20)

1. Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol 2012;60:428-431.
2. Romero-Aroca P. Managing diabetic macular edema: the leading cause of diabetes blindness. World J Diabetes 2011; 2:98-104.
3. Albert DM, Jakobiec FA. Principles and Practice of Ophthalmology. 2nd ed. Philadelphia, PA: WB Saunders Co; 2000.
4. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinop-athy and other retinal disorders. N Engl J Med 1994;331: 1480-1487.
5. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 2008;115:1447-1449.
6. Diabetic Retinopathy Clinical Research Network. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology 2010;117:1064-1077.
7. Diabetic Retinopathy Clinical Research Network. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology 2012;119:2312-2318.
8. RESTORE Study Group. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 2011;118: 615-625.
9. Funatsu H, Noma H, Mimura T, et al. Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 2009;116:73-79.
10. Kook D, Wolf A, Kreutzer T, et al. Long-term effect of intra-vitreal bevacizumab (Avastin) in patients with chronic diffuse diabetic macular edema. Retina 2008;28:1053-1060.
11. Arevalo JF, Sanchez JG, Wu L, et al. Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months. Ophthalmology 2009;116:1488-1497.
12. GENEVAStudy Group. The GENEVA study: randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-1146.
13. Diabetic Retinopathy Clinical Research Network. A phase 2 randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007;114:1860-1867.
14. Do DV, Nguyen QD, Boyer D, et al. The DA VINCI Study: phase 2 primary results of VEGF trap-eye in patients with diabetic macular edema. Ophthalmology 2011;118:1819-1826.
15. Massin P, Bandello F, Garweg JG, et al. Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study). Diabetes Care 2010;33:2399-2405.
16. Pearson PA, Comstock TL, Ip M, et al. Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year mul-ticenter, randomized, controlled clinical trial. Ophthalmology 2011;118:1580-1587.
17. RISE and RIDE Research Group. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012; 119:789-801.
18. Nakao S, Arima M, Ishikawa K, et al. Intravitreal anti-VEGF therapy blocks inflammatory cell infiltration and re-entry into the circulation in retinal angiogenesis. Invest Ophthalmol Vis Sci 2012;53:4323-4328.
19. Champlain Study Group. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 2011;31:915-923.
20. Sharma A, Madhusudhan RJ, Nadahalli V, et al. Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: a case report. Indian J Ophthalmol 2012;60:234-235.